Thursday, March 10, 2016

Bill Ackman Jumps Deeper Into Toxic Valeant Pharmaceuticals With Board Nominee

As the third biggest shareholder in Valeant Pharmaceuticals, Bill Ackman has an ambivalent prognosis on the company's current woes.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)